Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$4.41
+0.81%
Mkt Cap $1.34B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
Implied Upside
+217.5%
Consensus $14.00 vs current $4.41
NASDAQ·Healthcare·Biotechnology
$4.41
+0.81%
Mkt Cap $1.34B
Buy
6
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
+217.5%
Consensus $14.00 vs current $4.41